DASTY - Dassault Systèmes SE

Other OTC - Other OTC Delayed Price. Currency in USD
140.79
-0.51 (-0.36%)
At close: 3:57PM EDT
Stock chart is not supported by your current browser
Previous Close141.30
Open142.44
Bid0.00 x 0
Ask0.00 x 0
Day's Range140.23 - 142.55
52 Week Range109.24 - 166.07
Volume8,201
Avg. Volume9,890
Market Cap36.615B
Beta (3Y Monthly)0.91
PE Ratio (TTM)54.99
EPS (TTM)2.56
Earnings DateN/A
Forward Dividend & Yield0.73 (0.52%)
Ex-Dividend Date2019-05-24
1y Target Est181.00
Trade prices are not sourced from all markets
  • GlobeNewswire

    Dassault Systèmes Announces Medidata Stockholder Approval for Planned Acquisition

    PA) and Medidata Solutions, Inc. ("Medidata") (MDSO) announced that Medidata stockholders have approved on August 16, 2019 the proposed acquisition of Medidata by Dassault Systèmes. At a special meeting of Medidata stockholders held on August 16, 2019, 78% of Medidata’s total outstanding common stock voted in favor of the proposed acquisition and 99% of shares voted were in favor of the proposed acquisition.

  • What Dassault Systèmes SE's (EPA:DSY) ROE Can Tell Us
    Simply Wall St.

    What Dassault Systèmes SE's (EPA:DSY) ROE Can Tell Us

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

  • GlobeNewswire

    Dassault Systèmes: disclosure of trading in own shares

    Vélizy-Villacoublay, August 5, 2019 DISCLOSURE OF TRADING IN OWN SHARES(Repurchase program decided by the General Meeting of Shareholders of May 23, 2019) Issuer: Dassault.

  • GlobeNewswire

    Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of July 31, 2019

    Declaration of the number of outstanding shares and voting rightsas of July 31, 2019 Vélizy-Villacoublay (France) August 5, 2019 – Dassault Systèmes (Euronext Paris: #13065,.

  • Dassault Systemes Earnings: Still on Track in 2019
    Motley Fool

    Dassault Systemes Earnings: Still on Track in 2019

    The engineering software company's earnings report wasn't without blemishes, but its growth prospects look good.

  • GlobeNewswire

    Dassault Systèmes: Availability of Dassault Systèmes' 2019 Half-Year Financial Report

    Availability of Dassault Systèmes’ 2019 Half-Year Financial Report (IFRS Half-Year Consolidated Condensed Financial Statements) Vélizy-Villacoublay, France – July 25,.

  • GlobeNewswire

    Dassault Systèmes and SATS Create World’s First Virtual Kitchen for In-Flight Catering Production

    Dassault Systèmes and SATS Create World’s First Virtual Kitchen for In-Flight Catering Production Dassault Systèmes collaborated with SATS, Asia’s leading food solutions and.

  • GlobeNewswire

    Dassault Systèmes Reports First Half Revenue and EPS Growth Up Double-digits, Reaffirms 2019 Financial Objectives

    Dassault Systèmes Reports First Half Revenue and EPS Growth Up Double-digits, Reaffirms 2019 Financial Objectives    VÉLIZY-VILLACOUBLAY, France — July 24, 2019 — Dassault.

  • GlobeNewswire

    Dassault Systèmes: Dassault Aviation Advances its Next Generation Enterprise Platform: 3DEXPERIENCE for All Programs

    Dassault Aviation Advances its Next Generation Enterprise Platform: 3DEXPERIENCE for All Programs Dassault Aviation will rely on six Dassault Systèmes industry solution.

  • Does Dassault Systèmes SE's (EPA:DSY) CEO Salary Compare Well With Others?
    Simply Wall St.

    Does Dassault Systèmes SE's (EPA:DSY) CEO Salary Compare Well With Others?

    In 2002 Bernard Charlès was appointed CEO of Dassault Systèmes SE (EPA:DSY). This analysis aims first to contrast CEO...

  • GlobeNewswire

    Dassault Systèmes : Half-year statement of the Liquidity contract between Dassault Systèmes and Oddo BHF SCA

    Half-year statement of the Liquidity contract between Dassault Systèmes and Oddo BHF SCA Vélizy-Villacoublay, France – July 17, 2019 — Dassault Systèmes (Euronext Paris:.

  • GlobeNewswire

    Dassault Systèmes : Update of the Liquidity contract

    Update of the liquidity contract Vélizy-Villacoublay (France) – July 17, 2019 — Dassault Systèmes (Euronext Paris: #13065, DSY.PA), “The 3DEXPERIENCE Company”, announces that.

  • Motley Fool

    Checking Up on 5 Stocks Celebrating the World Cup, 1 Year Later

    Back in July 2018, David Gardner picked these as investments to hold for four years -- till the next World Cup.

  • GlobeNewswire

    Dassault Systemes to Publish its Second Quarter 2019 Results, Webcast and Conference Call on July 24th 2019

    DASSAULT SYSTEMES TO PUBLISHITS SECOND QUARTER 2019 RESULTS,WEBCAST AND CONFERENCE CALL ON JULY 24th 2019     VÉLIZY-VILLACOUBLAY, France — July 11th, 2019 — Dassault.

  • GlobeNewswire

    Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of June 30, 2019

    Declaration of the number of outstanding shares and voting rightsas of June 30, 2019 Vélizy-Villacoublay (France) July 8, 2019 – Dassault Systèmes (Euronext Paris: #13065,.

  • What Does Dassault Systèmes SE’s (EPA:DSY) 13% ROCE Say About The Business?
    Simply Wall St.

    What Does Dassault Systèmes SE’s (EPA:DSY) 13% ROCE Say About The Business?

    Today we'll evaluate Dassault Systèmes SE (EPA:DSY) to determine whether it could have potential as an investment...

  • GlobeNewswire

    Dassault Systèmes Named Key Supplier by Groupe PSA for its Digital Transformation

    Dassault Systèmes Named Key Supplier by Groupe PSA for its Digital Transformation Dassault Systèmes becomes the first and only software provider today to be recognized as.

  • GlobeNewswire

    Dassault Systèmes: Dassault Systèmes Continues to Demonstrate Its Commitment to Life Sciences for Patient Experience by Investing in BioSerenity

    Dassault Systèmes Continues to Demonstrate Its Commitment to Life Sciences for Patient Experience by Investing in BioSerenity BioSerenity, developer of solutions dedicated.

  • GlobeNewswire

    Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Medidata Solutions (NASDAQ: MDSO) on Behalf of Medidata Shareholders and Encourages Medidata Investors to Contact the Firm

    NEW YORK, June 12, 2019 -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Medidata Solutions (NASDAQ: MDSO) on behalf of.

  • TheStreet.com

    Medidata Solutions Dips After $5.8 Billion Sale to France's Dassault Systemes

    shares traded lower Wednesday after it agreed a takeover offer from France's Dassault Systemes SE at a discount to its current market value. Dassault said it would pay $92.25 for each Medidata share in a deal that values the New York-based group at $5.8 billion. "Today marks a significant milestone for the Life Sciences industry and the value of the virtual world to address the complexity of developing personalized medicine and patient-centric experiences," said Dassault CEO Bernard Charles.

  • Dassault to Buy Medidata in $5.7 Billion Shift to Health
    Bloomberg

    Dassault to Buy Medidata in $5.7 Billion Shift to Health

    (Bloomberg) -- French technology company Dassault Systemes SE agreed to buy Medidata Solutions Inc., a software firm that analyzes clinical trials, for $5.7 billion to bolster its offerings to the pharmaceutical industry.The record deal will allow Dassault to offer drugmakers a complete set of services and ride a shift toward personalized medicine, in which research and tools are tailored to individual patient profiles, generating the need to analyze vast amounts of data.Health is becoming a crucial market for Dassault, which also creates 3D design software, said Pascal Daloz, the company’s chief financial officer. Medidata offers clients wearable sensors that help track patients’ health in real life and biomarker analysis to select which ones may best respond to drugs. It estimates that 13 of the top 15 medicines sold last year relied on its technology.“This is by far the largest acquisition we’ve ever made,” Daloz said on a conference call, highlighting Dassault’s interest in the health market.Drugmakers’ CostsThe all-cash transaction values Medidata at $92.25 a share -- 17% more than Medidata’s closing price on April 18, the last trading day before Bloomberg reported Dassault’s interest in the New York-based company. Medidata shares were down 3.5% to $91.45 at 9:59 a.m. in New York. Dassault fell 1.5% to 134.45 euros in Paris.The deal is expected to close in the final quarter of 2019 and start boosting earnings as early as 2020, the companies said in a statement.Drugmakers faced with rising development costs are outsourcing many parts of their research and development efforts, using specialized providers of services and technology.Medidata counts most of the biggest drug companies in the world as customers, according to supply-chain data compiled by Bloomberg. It provides a cloud-based subscription service that helps medical device, diagnostic and pharmaceutical companies manage and analyze clinical trials. Its revenue more than doubled from 2013 to 2018, when it brought in $635.7 million.Dassault, with a market value of 36 billion euros ($41 billion), offers software and services for industries ranging from aerospace and defense to consumer goods. The life sciences business counts many major pharma companies among its clients.The planned acquisition, endorsed by both boards, marks the first time the French company has resorted to external funding, according to Daloz. Dassault will finance the takeover with a 1 billion-euro loan, a 3 billion-euro bridge-to-loan facility and available cash.(Updates with Dassault shares in sixth paragraph.)\--With assistance from Liana Baker, Geraldine Amiel and Marie Mawad.To contact the reporters on this story: Ed Hammond in New York at ehammond12@bloomberg.net;Ruth David in London at rdavid9@bloomberg.net;Manuel Baigorri in Hong Kong at mbaigorri@bloomberg.netTo contact the editors responsible for this story: Elizabeth Fournier at efournier5@bloomberg.net, ;Giles Turner at gturner35@bloomberg.net, Jeff Sutherland, Thomas MulierFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

  • GlobeNewswire

    MEDIDATA SOLUTIONS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

    WILMINGTON, Del., June 12, 2019 -- Rigrodsky & Long, P.A.: Do you own shares of Medidata Solutions, Inc. (NASDAQ GS: MDSO)? Did you purchase any of your shares prior to.

  • TheStreet.com

    Tesla, Medidata, United Tech-Raytheon, Dave & Buster's - 5 Things You Must Know

    U.S. stock futures declined on Wednesday as optimism faded over a near-term trade deal between Washington and Beijing and Wall Street awaited a reading on U.S. inflation. Contracts tied to the Dow Jones Industrial Average fell 71 points, futures for the S&P 500 declined 8.65 points, and Nasdaq futures were down 37 points. Donald Trump said Tuesday he wouldn't agree to a trade deal unless China agrees to four or five "major points" that the president didn't specify.

  • Dassault to Buy Medidata in $5.7 Billion Health Data Push
    Bloomberg

    Dassault to Buy Medidata in $5.7 Billion Health Data Push

    (Bloomberg) -- Dassault Systemes SE, a maker of industrial design software, agreed to buy Medidata Solutions Inc. for $5.7 billion to gain a foothold in the fast-growing market for clinical trial technology.The deal pushes the French company further beyond its design roots into data processing and business analysis. Medidata’s software analyzes pharmaceutical and biotech trials for some of the world’s biggest drugmakers including Sanofi SA, Pfizer Inc. and AstraZeneca Plc.“This is by far the largest acquisition we’ve ever made,” Pascal Daloz, chief financial officer of Dassault Systemes, said on a conference call. He said health is becoming a crucial market for the company, whose customers are mostly in aerospace, defense and consumer goods.The all-cash deal values New York-based Medidata at $92.25 a share, 17% above its closing price on April 18, the last trading day before Bloomberg reported Dassault Systemes’ interest in the company. Medidata stock fell 4.4% to $90.60 in premarket trading.Shares in Dassault Systemes, which has a market value of 36 billion euros ($41 billion) and annual sales of 3.5 billion euros last year, fell as much as 3% before recouping some of the decline to trade down 1% at 11:31 a.m. in Paris.Personalized MedicineMedidata offers clients wearable sensors that help track patient health and biomarker analysis to select which patients may best respond to certain drugs. It estimates that 13 of the top 15 medicines sold last year relied on its technology, as the healthcare industry shifts towards personalized medicine and the targeting of individual patient profiles.President Donald Trump’s protectionist trade agenda hasn’t reduced the appetite of European companies for U.S. takeovers. In fact their appeal has been growing, potentially turning the tables after years in which Europe was mostly a target for U.S. acquirers.French advertising group Publicis Groupe SA announced its biggest ever takeover in April, a $4.4 billion deal for U.S.-based Alliance Data Systems Corp.’s digital marketing unit Epsilon.The Medidata deal is expected to close in the final quarter of 2019 and start boosting earnings as early as 2020, the companies said in a statement. Dassault Systemes will finance it with a 1 billion-euro loan, a 3 billion-euro bridge-to-loan facility and available cash. It’s the first time the French company has resorted to external funding, Daloz said.(Adds Medidata premarket share price in fourth paragraph.)\--With assistance from Liana Baker, Manuel Baigorri, Ruth David, Ed Hammond and Marthe Fourcade.To contact the reporters on this story: Marie Mawad in Paris at mmawad1@bloomberg.net;Geraldine Amiel in Paris at gamiel@bloomberg.netTo contact the editors responsible for this story: Giles Turner at gturner35@bloomberg.net, Thomas Pfeiffer, Frank ConnellyFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

  • MarketWatch

    Dassault offers to buy Medidata in $5.8 billion deal

    Dassault Systemes SE on Wednesday announced a definite agreement for U.S. technology group Medidata Solutions Inc. , in an agreement valued at $5.8 billion. Under terms of the all-cash deal, the French technology group will offer $92.25 for each share of Medidata, whose shares closed at $94.75 a share on Tuesday. The transaction was unanimously approved by the boards of directors of both companies.